A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine

被引:0
|
作者
Croop, R. [1 ]
Lipton, R. B. [2 ]
Kudrow, D. [3 ]
Stock, D. A. [1 ]
Kamen, L. [1 ]
Conway, C. M. [1 ]
Stock, E. G. [1 ]
Coric, V. [1 ]
Goadsby, P. J. [4 ,5 ]
机构
[1] Biohaven Pharmaceut, New Haven, CT USA
[2] Albert Einstein Coll Med, Bronx, NY 10467 USA
[3] Calif Med Clin Headache, Santa Monica, CA USA
[4] Kings Coll Hosp London, NIHR Wellcome Trust Kings Clin Res Facil, SLaM Biomed Res Ctr, Kings Coll, London, England
[5] Univ Calif Los Angeles, Neurol, Los Angeles, CA USA
来源
JOURNAL OF HEADACHE AND PAIN | 2021年 / 22卷 / SUPPL 1期
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
AL054
引用
收藏
页码:19 / 19
页数:1
相关论文
共 50 条
  • [41] Evaluating the Efficacy and Safety of Erenumab (AMG 334) In Chronic Migraine Prevention in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Study
    Tepper, Stewart
    Widnell, Katherine
    Dolezil, David
    Ashina, Messoud
    Reuter, Uwe
    Brandes, Jan Lewis
    Silberstein, Stephen
    Winner, Paul
    Leonardi, Dean
    Mikol, Dan
    NEUROLOGY, 2017, 88
  • [42] A PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ERENUMAB IN MIGRAINE PREVENTION: PRIMARY RESULTS OF THE ARISE TRIAL
    Dodick, David
    Ashina, Messoud
    Kudrow, David
    Lanteri-Minet, Michel
    Osipova, Vera
    Palmer, Kerry
    Picard, Hernan
    Mikol, Daniel D.
    Lenz, Robert A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (05):
  • [43] A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 in Patients with Diabetic Gastroparesis
    Lembo, Anthony
    Camilleri, Michael
    McCallum, Richard W.
    Sastre, Ramon F.
    Breton, Cristian F.
    Spence, Sharon C.
    White, Jeffery
    Gottesdiener, Keith
    Stoner, Elizabeth
    GASTROENTEROLOGY, 2014, 146 (05) : S158 - S159
  • [44] Efficacy and Safety of Cinnarizine in the Prophylaxis of Migraine in Children: A Double-Blind Placebo-Controlled Randomized Trial
    Ashrafi, Mahmoud Reza
    Salehi, Soodeh
    Malamiri, Reza Azizi
    Heidari, Morteza
    Hosseini, Seyed Ahmad
    Samiei, Mahboubeh
    Tavasoli, Ali Reza
    Togha, Mansoureh
    PEDIATRIC NEUROLOGY, 2014, 51 (04) : 503 - 508
  • [45] Efficacy and safety of bisacodyl in the acute treatment of constipation: a double-blind, randomized, placebo-controlled study
    Kienzle-Horn, S
    Vix, JM
    Schuijt, C
    Peil, H
    Jordan, CC
    Kamm, MA
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (10) : 1479 - 1488
  • [46] Safety and efficacy of tamsulosin in the treatment of painful ejaculation: a randomized, double-blind, placebo-controlled study
    M R Safarinejad
    International Journal of Impotence Research, 2006, 18 : 527 - 533
  • [48] Botulinum toxin as a preventive treatment for migraine:: a randomized double-blind placebo-controlled multi-centre study
    Petri, S
    Tölle, T
    Pfaffenrath, V
    Stefenelli, U
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S89 - S89
  • [49] Greater occipital nerve blockade for the preventive treatment of chronic migraine: A randomized double-blind placebo-controlled study
    Chowdhury, Debashish
    Tomar, Apoorva
    Deorari, Vaibhav
    Duggal, Ashish
    Krishnan, Anand
    Koul, Arun
    CEPHALALGIA, 2023, 43 (02)
  • [50] Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study
    Gupta, Pawan Kumar
    Maheshwari, Sunil
    Cherian, Joe Joseph
    Goni, Vijay
    Sharma, Arun Kumar
    Tripathy, Sujith Kumar
    Talari, Keerthi
    Pandey, Vivek
    Sancheti, Parag Kantilal
    Singh, Saurabh
    Verma, Nikhil N.
    Kumar, Uday
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2023, 51 (09): : 2254 - 2266